Externally-led Patient-Focused Drug Development Meeting for Food Allergy

The Food Allergy Collaborative invites you to attend the Externally-led Patient Focused Drug Development meeting for food allergy where patients will share their lived experience managing and treating food allergy with FDA representatives. Tune in on our streaming platform to hear patient testimonies to the FDA and submit your feedback during the open discussion portion of the meeting.

Date/Time: September 9, 2021 10:00 a.m. ET – 03:30 p.m. ET

Session 1 – Symptoms and Daily Impacts of Food Allergy

Topics will include:

  • What are the biggest challenges of having a food allergy?
  • How does having a food allergy impact your daily life and mental health?

Session 2 – Patients’ Perspectives on Prevention and Treatments for Food Allergy

Topics will include:

  • What challenges or barriers to epinephrine access have you encountered?
  • Are you/your child currently undergoing treatment for your food allergy?

Register below to live-stream the PFDD meeting on September 9. A viewing link will be sent before the meeting.

What is the Food Allergy Voice of the Patient Process?

Want to learn more about the Externally-led Patient Focused Drug meeting? This webinar will provide an overview of the US Food & Drug Administration (FDA) and the process of drug development. It will explain what the purpose of a Patient Focused Drug Development is and why it is important for the food allergy community. On behalf of the Food Allergy Collaborative, we will share with you how you can participate in the process and share your story.